News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,745 Results
Type
Article (42485)
Company Profile (437)
Press Release (671823)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (208916)
Career Advice (2023)
Deals (36027)
Drug Delivery (104)
Drug Development (83625)
Employer Resources (174)
FDA (16442)
Job Trends (15109)
News (353083)
Policy (33120)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2651)
Accelerated approval (6)
Adcomms (24)
Allergies (84)
Alliances (51008)
ALS (93)
Alzheimer's disease (1426)
Antibody-drug conjugate (ADC) (137)
Approvals (16430)
Artificial intelligence (262)
Autoimmune disease (25)
Automation (16)
Bankruptcy (372)
Best Places to Work (11853)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (330)
Bladder cancer (71)
Brain cancer (26)
Breast cancer (280)
Cancer (2228)
Cardiovascular disease (182)
Career advice (1689)
Career pathing (30)
CAR-T (152)
Cell therapy (429)
Cervical cancer (19)
Clinical research (67751)
Collaboration (859)
Compensation (527)
Complete response letters (24)
COVID-19 (2648)
CRISPR (42)
C-suite (244)
Cystic fibrosis (105)
Data (2128)
Decentralized trials (2)
Denatured (28)
Depression (49)
Diabetes (268)
Diagnostics (6417)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (99)
Earnings (87724)
Editorial (39)
Employer branding (21)
Employer resources (148)
Events (115800)
Executive appointments (726)
FDA (17677)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (778)
Gene editing (109)
Generative AI (20)
Gene therapy (315)
GLP-1 (744)
Government (4500)
Grass and pollen (4)
Guidances (52)
Healthcare (19179)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (127)
Indications (29)
Infectious disease (2793)
Inflammatory bowel disease (141)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (94)
Interviews (312)
IPO (16790)
IRA (43)
Job creations (3703)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (492)
Leadership (17)
Legal (8000)
Liver cancer (74)
Lung cancer (318)
Lymphoma (149)
Machine learning (6)
Management (58)
Manufacturing (305)
MASH (68)
Medical device (13538)
Medtech (13543)
Mergers & acquisitions (19761)
Metabolic disorders (706)
Multiple sclerosis (79)
NASH (19)
Neurodegenerative disease (98)
Neuropsychiatric disorders (33)
Neuroscience (1980)
NextGen: Class of 2025 (6766)
Non-profit (4558)
Northern California (2631)
Now hiring (39)
Obesity (382)
Opinion (223)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (82)
Parkinson's disease (153)
Partnered (21)
Patents (230)
Patient recruitment (106)
Peanut (47)
People (58701)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21282)
Phase II (29897)
Phase III (22108)
Pipeline (1165)
Policy (144)
Postmarket research (2602)
Preclinical (9095)
Press Release (67)
Prostate cancer (103)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (399)
Real estate (6023)
Recruiting (67)
Regulatory (22728)
Reports (46)
Research institute (2420)
Resumes & cover letters (351)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (74)
Series A (138)
Series B (89)
Service/supplier (11)
Sickle cell disease (57)
Southern California (2271)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3766)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (33)
The Weekly (48)
United States (23083)
Vaccines (696)
Venture capitalists (43)
Weight loss (253)
Women's health (37)
Worklife (16)
Date
Today (54)
Last 7 days (659)
Last 30 days (2439)
Last 365 days (33775)
2025 (10140)
2024 (36322)
2023 (41041)
2022 (52303)
2021 (56785)
2020 (54945)
2019 (47464)
2018 (35759)
2017 (33076)
2016 (32402)
2015 (38476)
2014 (32232)
2013 (27182)
2012 (29287)
2011 (29915)
2010 (28039)
Location
Africa (737)
Alabama (57)
Alaska (7)
Arizona (238)
Arkansas (14)
Asia (39361)
Australia (6608)
California (6070)
Canada (1983)
China (516)
Colorado (267)
Connecticut (278)
Delaware (142)
Europe (85859)
Florida (883)
Georgia (203)
Idaho (57)
Illinois (538)
India (25)
Indiana (309)
Iowa (12)
Japan (159)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (891)
Massachusetts (4606)
Michigan (218)
Minnesota (390)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (25)
Nevada (60)
New Hampshire (66)
New Jersey (1721)
New Mexico (30)
New York (1711)
North Carolina (1025)
North Dakota (7)
Northern California (2631)
Ohio (202)
Oklahoma (14)
Oregon (38)
Pennsylvania (1352)
Puerto Rico (11)
Rhode Island (33)
South America (1111)
South Carolina (22)
South Dakota (1)
Southern California (2271)
Tennessee (101)
Texas (900)
Utah (181)
Virginia (145)
Washington D.C. (63)
Washington State (566)
West Virginia (3)
Wisconsin (53)
714,745 Results for "ankasa regenerative therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
March 6, 2025
·
4 min read
Press Releases
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
April 16, 2025
·
4 min read
Press Releases
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
April 14, 2025
·
7 min read
Biotech Beach
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024
Regen BioPharma, Inc., a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on May 9, 2024.
May 7, 2024
·
3 min read
Press Releases
Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline
April 4, 2025
·
4 min read
Press Releases
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
February 3, 2025
·
8 min read
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
Press Releases
Doron Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MOTYS for Treatment of Symptoms Associated With Osteoarthritis
February 19, 2025
·
3 min read
Press Releases
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis with Cardiomyopathy
March 27, 2025
·
6 min read
Press Releases
Beacon Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for laru-zova (AGTC-501)
January 28, 2025
·
4 min read
1 of 71,475
Next
